All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.


OBJECTIVE To evaluate the safety and efficacy of all-trans retinoic acid to induce complete remission and to examine its effects on duration of remission and survival in patients with acute promyelocytic leukemia. DESIGN Phase II evaluation and comparison with historical control patients. SETTING Tertiary care cancer referral center. PATIENTS… (More)


  • Presentations referencing similar topics